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Summary 
Nineteen influenza virus strains were examined for susceptibility to 
amantadine-HC1 (AMT) and for pH-thresholds of haemagglutinin-induced 
haemolysis. Whereas pH-thresholds below 5.5 were not seen in AMT-resis- 
tant strains, AMT-sensitive strains showed pH-thresholds either below or 
above 5.5. 
The haemagglutinin (HA) molecule of influenza A and B viruses under- 
goes a eonformational change at tow pH in vitro. This property, well estab- 
lished in biological, biochemical, antigenetieal, and morphological studies 
(for review see 13), is genetically determined by the HA-gene (7, 18). The 
critical pH-threshold value is strain-dependent and differs in a wide range 
between pH 5.0 and 6.0. It has been found that endosomal nd lysosomal pH 
can reach low values, up t~) 5.0 (16) or 4.5 (9). Thus, it has been argued that 
the conformational change of HA also occurs in vivo and forms a necessary 
step during cell infection after endocytosis of the virus particles, triggering 
the fusion between viral and cellular membranes (17). 
Amantadine-hydrochloride (AMT), a potent inhibitor of many influenza 
strains in vivo and in vitro, increases the endo- and lysosomal pH. The maxi- 
mum effect of AMT on intralysosomal pH is reported as an increase up to 
5.5, in experiments with mouse peritoneal maerophages (9). It has been sug- 
gested that the inhibitory effect of AMT is caused by preventing the confor- 
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mational change of HA and, consequently, the membrane thsion of those 
influenza virus strains which require a low pH. Thus, sensitivity and resis- 
tance to amantadine could be expected to be determined by the HA-gene. In 
contrast, several authors have described influenza A strains and recombi- 
nants whose susceptibility to AMT seemed to be determined by the matrix- 
protein gene or by a combination of genes other than the HA-gene (8, 3, 14). 
Bearing in mind the studies of SCHO•TlSSEK & FAULK~ER (14), HAY & 
ZAMBO~ (4), Oxford (10) and DA~IELS et al. (1), we established the following 
working hypothesis: 
AMT has at least wo different and genetically independent modes of in- 
hibiting virus production, one of these involving HA as a target. Any virus 
strain can be sensitive to AMT either on both locations or steps in the repli- 
cation circle, or on one or on none. Thus, a strain not requiring an endo- or 
lysosomal pH lower than 5.5 for its HA to undergo the conformational 
change, may be sensitive or resistant depending on the susceptibility of the 
alternative target. However, a strain which does require a pH lower than 5.5 
for membrane fusion is always sensitive to AMT, regardless of other mecha- 
nisms. 
This study describes the correlation between AMT-suseeptibflity in a 
monkey kidney cell-line model and the pH-haemolysis-threshold for 16 
influenza A strains of 5 different subtypes and 3 influenza B strains, among 
them strains from our laboratory collection and some reeombinants and 
mutants with well-doeumentated AMT-suseeptibility. For names, abbrevia- 
tions and source see Table 1. 
Viruses were propagated in the allantoie cavity of ll-day-old embryonat- 
ed chicken eggs and then adapted to a continuous monkey kidney cell-line 
(LLC-MK2), Flow Laboratories Ltd., Irvine, Scotland). For haemolysis 
tests, ~drus-containing fluids were clarified by slow eentrifugation and puri- 
fied by adsorption to and elution from chicken erythroeytes in PBS. 25 txl of 
virus suspensions (> 1000 haemagglutination units/ml) were added to 
2.0 ml of 2 per cent fresh chicken erythroeytes in saline buffered with 0.1 M 
citric ac id -sod ium citrate at pHs varying from 5.0 to 6.0 in steps of 
0.1 units. After two incubation steps at 4°C for 1 hour and 37 °C for 1 hour, 
respectively, the erythrocytes were sedimentated by centrifugation and 
supernatants were measured photometrically for haemoglobin at 540 nm. 
This was a slightly modified version of the haemolysis assay of KIDA 
et al. (5). Erythrocytes not coated with virus served as controls for each pH. 
Haemolysis of controls was not dependent on pH between 6.0 and 5.0, so 
that their extinctions over the whole pH-range could be used to form a thre- 
shold (mean +_ 2 SD) between spontaneous and virus-induced haemolysis. 
The pH-threshold of the virus was defined as the pH-value, at which virus- 
induced haemolysis occurred first with decreasing pH. Figure 1 shows a 
typieM ex- periment involving A/Bk/79.  Experiments were done in dupli- 
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Table 1. Virus strains' and abbreviatior~s used in this study 
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Haemagglutinin- 
subtype Strain Abbreviation 
A-H 1 A/Wilson Smith/33 (H 1 N 1) A/WS/33 
A/Puerto Rico/8/34 (H 1 N l) A/PR/8 
A/Brazi l / l l /78 (H 1 N 1) A/Bra/78 
A/ Japan/305/57 (H 2 N 2) A/ Jap/57 
A/equine/Miami/ i /63 (H 3 N 8) A/eq/63 
A/Aichi/2/68 - A /PR/8  - 
recombinant (H 3 N 2)* A/X 31 
2 AMT-resistant 
mutants of A/X 31" 
A-H 2 
A-H3 
A-H 7 
A-H 10 
B 
A/Victoria/3/75 (H 3 N 2) 
A/Texas/ l /77 (H 3 N 2) 
A/Bangkok/I /79 (H 3 N 2) 
A/FPV/t~ostock/34 (H 7 N I) 
2 A /FPV-  A/eq/63 - recombinants 
with tL4_ from A/FPV** 
A/FPV - A/turkey/England/63 (H 7 N 3)- 
recombinant with HA from the latter** 
A/FPV - A/chick/Germany/N/49 (H 10 N 7)- 
recombinant with I~A from the latter** 
B/Lee/40 
B/Hong Kong/8/73 
B/Singapore/222/79 
A/X  31-1 a 
A/X  31-ab 4 
A/Vie/75 
A/Tex/77 
A/Bk/79 
A/FPV 
A/FPV-19 
A/FPV-263 
A /FPVd l  
A/FPV-5 
B/Lee/40 
B/Hk/73 
B/Sing/79 
* Kindly provided by Dr. J. J. SKEHEL, London, England. Production and characteriza- 
tion of mutants has been described by DANIELS et al. (1), where A /X  31/1 a is designat- 
ed as "X-31 mutant 1 a". A /X  31-ab 4 is a mutant, with a single amino acid change His - 
Arg in position 17 of HA 1 (J. J. SKEHEL, personal communication). 
** Kindly provided by Dr. C. SCttOLTISSEK, Giessen, Federal Republic of Germany. Pro- 
duction of recombinants from A/FPV has been described by SCHOLTfSSEK & FAULK- 
MEn (14). In. A/FPV-19 genome segments 2 and 5 and in A/FPV-263 segments 3 and 8 
are replaced by A/eq/63, in A/FPV-11 segments 1, 2, 4, 6, 7 and 8 by A/turkey/Eng- 
land/63 and in A/FPV-5 segments 3, 4, 5 and 8 by A/chick/Germany/N/49 
(C. SCIJO:LTISSEK, personal communication). Genome 4 codes for HA. 
The other virus strains were t~om our collection. For passage history see RUIGROS: et 
aI. (13). 
care  and  repeated  at  leas t  twice.  The  assay  was  h igh ly  reproduc ib le ,  wi th  
on ly  a few d isc repanc ies  of 0.1 between exper iments .  The  resu l ts  for M1 
v i ruses  are  presented  in Tab le  2. We have  a l ready  pub l i shed  the  pH- thres -  
ho ld -va lues  of  some of the  s t ra ins  presented  here,  determined by  mon i to r ing  
morpho log ica l  changes  of  I IA  by  e leet ronmicroscopy  and  by  tr~2asin dige- 
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Fig. 1. Single haemolysis experiment for A/Bk/79. With decreasing pH, haemolysis ofvi- 
rus-coated erythroeytes (0= mean of two determinations) exceeds pontaneous haemoly- 
sis, as determined by 22 controls (__ = mean of controls ~ 2 SD), first at a pH of 5.3. This 
value was defined as the pH-threshold of A/Bk/79 in this experiment 
stion (13). The results of this paper are in agreement with t ose previous 
findings. 
In the literature, a great discrepancy exists with respect to the AMT-sus- 
ceptibility of several influenza A reference strains. For instance, A /PR/8  is 
reported to be resistant (8), relatively resistant (14) or sensitive (2). Sev- 
eral reasons for these conflicting results may be considered: Firstly, old re- 
ference strains such as A /PR/8  (isolated in 1934), have a propagation histo- 
ry differing for each laboratory as regards host cell systems and passage 
number. This can influence the biological properties of, among others, 
their HA (11, 15) by genetic mutation and make comparison of results bet- 
ween laboratories difficult or impossible. Secondly, several assays broadly 
measure any decrease in the net virus production, while others may focus on 
certain stages during penetration and replication. SCHOLTISSEK & FAULK- 
~ER (14) demonstrated strains which changed their susceptibility to AMT 
when measured either by a single or by a multiple growth cycle assay, and 
suggested tile existence of different and independent targets ofAMT-suscep- 
tibility. Thirdly, there are differences in the choice of host cells and in the 
actual concentration of AMT. 
For our purposes, an AMT-susceptibility assay should meet he following 
conditions: 
The virus pools used for both the haemolysis assay and the susceptibility 
assay should be obtained from the same host cell system and the same pas- 
sage. 
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The susceptibility assay should measure any difference of the net virus 
production between absence and presence of a maximum concentration of 
AMT and should lead to clear-cut results. 
We chose a test similar to the monkey kidney cell model of GRUNERT & 
HOFFMANN (2). In short, confluent monolayers ofLLC-MK 2 cells, produced 
in tissue culture cluster plates and maintained in 5 mt serum-free Dulbecco's 
modification of Earle's medium 199, were pretreated or not with 25 ~xg/ml 
AMT (no A-1260, Sigma Chemical Company, St. Louis, M0, U.S.A.) for 2 
hours. Then, all plates were infected with 0.2 ml of 10-fold virus dilutions 
through the end point of infectivity. The AMT-pretreated cells also received 
25 ~g/ml AMT in the maintenance medium. Cell-controls contained either 
maintenance medium only or medium with 25 pg/ml AMT. AMT-concentra- 
tions higher than 25 vg/ml rapidly led to rounding up and death of the cells. 
After two days the cells were harvested by three circles of freeze-thawing 
and the fluids were tested for haemagglutination activity by standard titra- 
tion with fresh chicken erythrocy~ms. Cell controls without virus and with or 
without AMT showed no HA-titres. Virus titres were expressed as the loga- 
rithmated reciprocal of the dilution of the seed virus which was associated 
with a 50 per cent decrease of the maximum haemagglutination activity (12). 
Two typical examples of virus growth with or without 25 ~g/ml AMT are 
presented in Figure 2. In an experiment, with A /PR/8 ,  untreated cells pro- 
duced a virus titre of 5.1, but cells treated with 25 pg/ml AMT produced a
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Fig. 2. Virus production in AMT-treated or untreated LLC-MK 2-cells. On abscissa, the 
logarithmated reciprocals of the dilutions of the virus used to infect LLC-MK 2-cells on 
day 0. On ordinate, the HA concentration ofharvested virus on day- 2 from untreated (Q) or 
AMT-treat~d (O) cells (< 2 = no haemagglutination bserved). Maximum HA-activity (,) 
and calculated ilution of 50 per cent maximum ttA-aetivity (4) (= virus titre) are marked. 
a Single experiment with A /PR/8 .  Difference between virus titres from untreated and 
AMT-treat~d cells (at) is 1.8. b Single experiment with A /FPV showing aht  of 0.1. 
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t i t re  of  3.3, resu l t ing  in a d i f ference between t i t res  (At) of  1.8 (Fig. 2 a). 
However ,  when A /FPV was  u ed,  At  was  on ly  0.1 (Fig. 2 b). Repeated  expe-  
r iments  a l lowed the  ca lcu la t ion  of  95 per  cent  conf idence  in terva ls  (95 per  
cent  CI) for At. A v i rus  s t ra in  was  regarded as AMT- res i s tant  when At in- 
c luded zero in the  95 per  cent  CI of  repeated  exper iments ,  and  vice versa .  A 
c lear -cut  dec is ion  between res i s tance  and  sens i t iv i ty  o AMT was  poss ib le  
for al l  s t ra ins  (Table  2). 
Table 2. pH-threshold-values and amantadine suceptibility of 19 virus strains 
AMT-susceptibility 
Strain pH-threshold no* At** 95% CI susceptible*** 
A/WS/33 5.7 3 1.6 1.1--2.1 + 
A/PR/8 5.3 4 1.6 1.2-2.0 + 
A/Bra/78 5.2 3 1.7 1.1-2.3 + 
A/ Jap/57 5.7 3 2.8 2.1-3.5 + 
A/eq/63 5.3 3 0.7 0.5-0.9 + 
A/X 31 5.4 3 1.6 1.0-2.3 + 
A/X31-1 a 5.6 3 0.2 0.1--0.4 - 
A /X  31-ab 4 5.9 3 --0.1 -0.8--0.6 - 
A/Vie/75 5.2 4 2.7 1.3-5.3 + 
A/Tex/77 5.1 3 2.7 2.0--3.3 + 
A/Bk/79 5.3 3 2.7 2.3-3. I  + 
A/FPV 6.0 3 --0.2 -0 .8 -0 .4  -- 
A/FPV-19 6.0 3 0. I -0 .6 -0 .8  - 
A/FPV-263 6.0 3 -0.3 -1 .2 -0 .6  - 
A/FPV-11 5.9 3 2.0 1.5-2.5 + 
A/FPV-5 5.3 5 1.6 0.6-2.5 + 
B/Lee/40 5.5 4 -0.1 -0 .6 -0 .5  - 
B/Hk/73 5.8 3 0.1 -0 .2 -0 .4  - 
B/Sing/79 5.9 3 -0.1 -0 .4 -0 .2  - 
* Number of experiments 
** Mean difference between virus titres produced by untreated and AMT-treated LLC- 
MK 2-cells 
*** +, sensitive to AMT (zero not included in 95% CI) 
- ,  resistant o AMT (zero included in 95% CI) 
A l l  natura l ly  occur r ing  human in f luenza A s t ra ins ,  inc lud ing A /Pg /8 ,  
were  found to be sens i t ive  to AMT,  in cont ras t  to the  three  in f luenza B 
s t ra ins  and  the  av ian  s t ra in  A /FPV.  Al l  s t ra ins  prov ided  by  Dr.  SCI~OLTIS- 
SEK (see Tab le  1, remark  **), showed a suscept ib i l i ty  in accordance  wi th  the  
resu l t s  of  his mul t ip le  cyc le  tes t  (14). Those  A /FPV- reeombinants  which had  
obta ined  the  I tA -gene  f rom A/FPV,  were  a lso res i s tant  (A /FPV-19  and  A /  
FPV-263) ,  whereas  A /FPV-11  and  A /FPV-5 ,  recombinants  w i th  the HA-  
gene f rom an AMT- res i s tant  parent  (14), tu rned  out  to be sensi t ive.  The  
AMT- res i s tanee  of  the  two mutants  of  A /X  31 was  conf i rmed.  
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It was not possible to perform direct measurements on endo- or lysoso- 
mal pH. Moreover, it snot yet clear whether influenza virus uncoating takes 
place in secondary l sosomes or already in primary endosomes (19, 20); 
drug-effects may be ditl~rent for the two organelles (F. 1~. MAXFIELD, New 
York, personal communication). Nevertheless, we assumed that the monkey 
kidney cells used in this study would not show significant differences to 
those data reported (9). 
Our findings were compatible with the working hypothesis saying that 
influenza strains fusing at pH-values lower than 5.5 are inhibited by AMT, 
regardless of other possible mechanisms ofthis drug. Indeed, none of the 19 
strains exhibited acombination oflow pH-threshold and resistance toAMT, 
while the other three combinations could be found (Table 3). In particular, 
three influenza A strains were sensitive to AMT, but possessed a high pH- 
threshold emonstrating the existence of drug-effects during viral entry and 
replication other than that on the conformational change of HA. Moreover, 
while the AMT-sensitive mother strain fused at low pH (5.4), the two mu- 
tants A/X 31-ab 4 and A/X 31-1 a which had obviously obtained resistance 
to AMT only but by a single point mutation on the HA-gene (1), showed a 
rise in the pH-threshold beyond 5.5, suggesting that they had acquired their 
resistance by escaping the need for a low pH for membrane fusion. 
Table 3. Influenza A and B strains subdivided according to their AMT-susceptibility and their 
pH haemolysis threshold 
pH-haemolysis-threshold 
pH<5.5 pH-->5.5 
AMT-susceptibility 
sensitive 
resistant none 
A/PR/8 
A/Bra/78 
A/eq/63 
*A/X 31 
A/Vic/75 
A/Tex/77 
A/Bk/79 
A/FPV-5 
A/WS/33 
A/ Jap/57 
A/FPV-t l  
A/FPV 
A/FPV-19 
A/FPV-263 
*A/X 31-1 a 
*A/X 31-ab 4 
B/Lee/40 
B/Hk/73 
B/Sing/79 
* Note position of sensitive mother strain A/X 31 (tow pH-threshold) and AMT-resistant 
mutants A/X 31-1 a and A/X 31-4 ab (high pH-threshold). 
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I t  would be interesting to study the AMT-susceptibil ity of low pH-mu- 
tants from mother  strains resistant o AMT and with a high pH-threshold 
which must be mutagenized and selected under low pH conditions (methods 
described by K~LIAN et al. [6] for Semliki Forest  virus). These mutants 
would be expected to become sensitive to AMT. I t  could even be attempted 
to produce AMT-sensitive influenza B strains in this way. 
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